Gist with a twist-upregulation of pdgf-b resulting in metachronous gastrointestinal stromal tumor and dermatofibrosarcoma protuberans

Journal of Gastrointestinal Surgery

Volumn 14, Issue 2, 2010, Pages 398-403

  McCarthy, Colin J ^a   O'Brien, Gavin C ^a   Cummins, Robert J ^a   Kay, Elaine W ^a   Broe, Patrick J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Dermatofibrosarcoma protuberans; DFSP; Gastrointestinal stromal tumor; GIST; Glivec; Imatinib; Metachronous; PDGF B; PDGFR

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B;

ARTICLE; BIOSYNTHESIS; CASE REPORT; DERMATOFIBROSARCOMA PROTUBERANS; GASTROINTESTINAL STROMAL TUMOR; HUMAN; MALE; METABOLISM; MIDDLE AGED; SECOND CANCER; SKIN TUMOR; STOMACH TUMOR; UPREGULATION;

DERMATOFIBROSARCOMA; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SKIN NEOPLASMS; STOMACH NEOPLASMS; UP-REGULATION;

EID: 77951884053     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1088-z     Document Type: Article

References (22)

1. Kindblom LG, Meis-Kindblom J, Bumming P et al. Incidence, prevalence, phenotype, and biologic spectrum of gastrointestinal stromal tumors (GIST)-a population-based study (abstract). Ann Oncol 2003; 13: 157.
2. Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG. Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer 2005; 117(2): 289-293.
3. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30(10): 1213-1220.
4. Darnell A, Dalmau E, Pericay C, Musulén E, Martín J, Puig J, Malet A, Saigí E, Rey M. Gastrointestinal stromal tumors. Abdom Imaging 2006; 31(4): 387-399.
5. Gutierrez JC, De Oliveira LO, Perez EA, Rocha-Lima C, Livingstone AS, Koniaris LG. Optimizing diagnosis, staging, and management of gastrointestinal stromal tumors. J Am Coll Surg 2007; 205(3): 479-491.
6. Joensuu H, Fletcher C, Dimitrijevic S et al. Management of malignant gastrointestinal stromal tumors. Lancet Oncol 2002; 3: 655-664.
7. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279(5350): 577-580.
8. Emile JF, Theou N, Tabone S, Cortez A, Terrier P, Chaumette MT, Julie C, Bertheau P, Lavergne-Slove A, Donadieu J, Barrier A, Le Cesne A, Debuire B, Lemoine A. Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors. Clin Gastroenterol Hepatol 2004; 2(7): 597-605.
9. Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res 2004; 64(17): 5913-5919.
10. Steigen SE, Eide TJ, Wasag B, Lasota J, Miettinen M. Mutations in gastrointestinal stromal tumors-a population-based study from Northern Norway. APMIS 2007; 115(4): 289-298.
11. Gloster HM Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996; 35(3 Pt 1): 355-374.
12. Patel KU, Szabo SS, Hernandez VS, Prieto VG, Abruzzo LV, Lazar AJ, López-Terrada D. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum Pathol 2007; 39(2): 184-193.
13. Gibson S, Sebire NJ, Anderson J. Platelet-derived growth factor receptors and ligands are up-regulated in paediatric fibromatoses. Histopathology 2007; 51(6): 752-757. Epub 2007 Oct 17.
14. Appolloni I, Calzolari F, Tutucci E, Caviglia S, Terrile M, Corte G, Malatesta P. PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. Int J Cancer 2008; 124(10): 2251-2259.
15. Liszka Ł, Zielińska-Pajak E, Pajak J, Gołka D, Huszno J. Coexistence of gastrointestinal stromal tumors with other neoplasms. J Gastroenterol 2007; 42(8): 641-649.
16. Agaimy A, Wünsch PH, Sobin LH, Lasota J, Miettinen M. Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Semin Diagn Pathol 2006; 23(2): 120-129.
17. Pasini B, Matyakhina L, Bei T, Muchow M, Boikos S, Ferrando B, Carney JA, Stratakis CA. Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: a case associated with a germline V561D defect. J Clin Endocrinol Metab 2007; 92(9): 3728-3732.
18. Liegl B, Gülly C, Reich O, Nogales FF, Beham A, Regauer S. Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations. Histopathology 2007; 50(4): 448-452.
19. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992; 52: 3213-3219.
20. Li M, Jendrossek V, Belka C. The role of PDGF in radiation oncology. Radiat Oncol. 2007; 2: 5.
21. Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA, Ferrando B, Pacak K, Assie G, Baudin E, Chompret A, Ellison JW, Briere JJ, Rustin P, Gimenez-Roqueplo AP, Eng C, Carney JA, Stratakis CA. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 2008; 16(1): 79-88.
22. Jones AV, Cross NC. Oncogenic derivatives of platelet-derived growth factor receptors. Cell Mol Life Sci 2004; 61(23): 2912-2923.